Tokyo court dismisses NTK's claims against Daiichi Sankyo; costs on NTK

0 min read | Published on 11 Sept 2026, 01:16 PM |Updated on 11 Sept 2026, 01:59 PM

Reviewed by

Riya DScanX News Team

Add as a preferred
source on Google

Key Highlights

Tokyo District Court dismissed all claims by NTK against Daiichi Sankyo on September 10, 2026
NTK is required to bear the full costs of the litigation proceedings
Fortis Healthcare disclosed the outcome under SEBI Regulation 30 on September 11, 2026
NTK plans to review the judgment and pursue further legal remedies

*this image is generated using AI for illustrative purposes only.

Fortis Healthcare disclosed that the Tokyo District Court dismissed all claims filed by Northern TK Venture Pte Ltd (NTK) against Daiichi Sankyo Company, Limited on September 10, 2026.

Case outcome summary

The court ruled that NTK, the promoter shareholder of Fortis Healthcare, must bear the costs of the litigation. The judgment was delivered following proceedings initiated by NTK before the Tokyo District Court in Japan.

Fortis Healthcare made this disclosure under Regulation 30 of SEBI Listing Regulations on September 11, 2026, referencing an announcement by IHH Healthcare Berhad on the Malaysian Stock Exchange and SGX Stock Exchange dated September 10, 2026.

NTK's response

NTK stated it respectfully disagrees with the decision and maintains confidence in the merits of its position. The company is reviewing the judgment with its legal counsel to evaluate all available legal remedies.

NTK remains committed to protecting its rights through appropriate legal channels. No specific timeline or nature of next steps was disclosed in the filing.

Historical Stock Returns for Fortis Healthcare

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-0.76%	-3.81%	-5.98%	+4.01%	-10.66%	+218.41%

How might NTK's potential appeal or further legal action impact the timeline and certainty of the Fortis Healthcare-IHH Healthcare merger?

What are the immediate financial implications for Fortis Healthcare regarding the litigation costs awarded against NTK, and will this affect its balance sheet?

Could this legal victory strengthen IHH Healthcare's negotiating position in any remaining regulatory or shareholder approvals for the acquisition?

Fortis Healthcare

View Company Insights

View All News

Fortis Healthcare releases transcript of September 4 investor call

1 min read | Published on 01 Sept 2026, 08:08 PM |Updated on 10 Sept 2026, 03:31 PM

Reviewed by

Shriram SScanX News Team

Add as a preferred
source on Google

Key Highlights

Fortis Healthcare released the transcript of its September 4, 2026 investor call
Management addressed the Delhi High Court's order for a forensic audit
IHH confirmed no impediment to strategic plans or capital infusion
Audit scope includes examination of share dissipation by erstwhile promoters

*this image is generated using AI for illustrative purposes only.

Fortis Healthcare has published the transcript of its joint meeting with analysts and investors held on September 4, 2026. The session featured management from Fortis Healthcare and IHH Healthcare Berhad addressing recent legal developments.

Meeting details

The interaction served as a virtual group call to provide updates on the Delhi High Court's order directing a forensic audit. No unpublished price-sensitive information (UPSI) was discussed during the session.

Parameter	Details
Date	September 4, 2026
Time	1:50 pm IST
Mode	Virtual Conference
Participants	Analysts and investors

Such meetings serve as a structured forum for the company to engage directly with the investment community, providing an opportunity for stakeholders to seek clarity on operational matters.

Transcript access

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the transcript is accessible via the company’s investor relations page. The event occurred on Friday, September 4, 2026, at 1:50 pm IST.

Participants who missed the live session can read the full transcript through the link provided on the official website. The audio recording was also available from September 4 to September 11, 2026, via +91 22 7194 5757 using playback ID 15861.

Historical Stock Returns for Fortis Healthcare

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-0.76%	-3.81%	-5.98%	+4.01%	-10.66%	+218.41%

How might the findings of the Delhi High Court-mandated forensic audit impact Fortis Healthcare's future financial reporting and regulatory compliance costs?

What are the potential implications for the pending merger or strategic partnership between Fortis Healthcare and IHH Healthcare Berhad given these legal developments?

Could the ongoing legal scrutiny affect Fortis Healthcare's ability to secure new debt financing or maintain its current credit ratings in the near term?

Fortis Healthcare

View Company Insights

View All News